BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 10388343)

  • 1. Inborn defects of fatty acid oxidation: a preventable cause of SIDS.
    Keppen LD; Randall B
    S D J Med; 1999 Jun; 52(6):187-8; disscussion 188-9. PubMed ID: 10388343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medium-chain acyl-CoA dehydrogenase deficiency.
    Egidio RJ; Francis GL; Coates PM; Hale DE; Roesel A
    Am Fam Physician; 1989 May; 39(5):221-6. PubMed ID: 2718899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of medium-chain acyl-CoA dehydrogenase deficiency G-985 mutation in sudden infant death syndrome.
    Miller ME; Brooks JG; Forbes N; Insel R
    Pediatr Res; 1992 Apr; 31(4 Pt 1):305-7. PubMed ID: 1570195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited metabolic diseases in the sudden infant death syndrome.
    Holton JB; Allen JT; Green CA; Partington S; Gilbert RE; Berry PJ
    Arch Dis Child; 1991 Nov; 66(11):1315-7. PubMed ID: 1755645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic deficiencies and SIDS.
    Bonham JR; Downing M
    J Clin Pathol; 1992 Nov; 45(11 Suppl):33-8. PubMed ID: 1474157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of medium-chain acyl-CoA dehydrogenase deficiency causing sudden death.
    Kelly DP; Whelan AJ; Hale DE; Rinaldo P; Rutledge SL; Zhang Z; Strauss AW
    Prog Clin Biol Res; 1992; 375():463-72. PubMed ID: 1438388
    [No Abstract]   [Full Text] [Related]  

  • 7. Fatty acid oxidation disorders as primary cause of sudden and unexpected death in infants and young children: an investigation performed on cultured fibroblasts from 79 children who died aged between 0-4 years.
    Lundemose JB; Kølvraa S; Gregersen N; Christensen E; Gregersen M
    Mol Pathol; 1997 Aug; 50(4):212-7. PubMed ID: 9350306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of mitochondrial fatty acid oxidation defects.
    Duran M; Bruinvis L; Ketting D; Dorland L
    Padiatr Padol; 1993; 28(1):19-25. PubMed ID: 8446424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of genotype-phenotype correlations and outcome in MCAD deficiency diagnosed by newborn screening in New York State.
    Arnold GL; Saavedra-Matiz CA; Galvin-Parton PA; Erbe R; Devincentis E; Kronn D; Mofidi S; Wasserstein M; Pellegrino JE; Levy PA; Adams DJ; Nichols M; Caggana M
    Mol Genet Metab; 2010 Mar; 99(3):263-8. PubMed ID: 20036593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mutation in medium chain acyl-CoA dehydrogenase causes sudden neonatal death.
    Brackett JC; Sims HF; Steiner RD; Nunge M; Zimmerman EM; deMartinville B; Rinaldo P; Slaugh R; Strauss AW
    J Clin Invest; 1994 Oct; 94(4):1477-83. PubMed ID: 7929823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sudden infant death syndrome gene: does it exist?
    Opdal SH; Rognum TO
    Pediatrics; 2004 Oct; 114(4):e506-12. PubMed ID: 15466077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with the 3-phenylpropionic acid loading test for diagnosis of medium-chain acyl-CoA dehydrogenase deficiency (MCADD).
    Lehnert W
    Padiatr Padol; 1993; 28(1):9-12. PubMed ID: 8446429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in 2 patients with symptoms of Reye syndrome].
    Brus F; Smit GP; Knoester H; Reijngoud DJ
    Tijdschr Kindergeneeskd; 1988 Jun; 56(3):132-7. PubMed ID: 3046055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid oxidation defects as causes of unexpected death in infancy.
    Bennett MJ; Allison F; Pollitt RJ; Variend S
    Prog Clin Biol Res; 1990; 321():349-64. PubMed ID: 2326299
    [No Abstract]   [Full Text] [Related]  

  • 15. Whole blood levels of dodecanoic acid, a routinely detectable forensic marker for a genetic disease often misdiagnosed as sudden infant death syndrome (SIDS): MCAD deficiency.
    Kemp PM; Little BB; Bost RO; Dawson DB
    Am J Forensic Med Pathol; 1996 Mar; 17(1):79-82. PubMed ID: 8838477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders.
    Millington DS; Terada N; Chace DH; Chen YT; Ding JH; Kodo N; Roe CR
    Prog Clin Biol Res; 1992; 375():339-54. PubMed ID: 1438380
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
    Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P
    Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Brugada ECG pattern in a neonate.
    Sanatani S; Mahkseed N; Vallance H; Brugada R
    J Cardiovasc Electrophysiol; 2005 Mar; 16(3):342-4. PubMed ID: 15817096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and quantitation of acylcarnitines in plasma and blood spots from patients with inborn errors of fatty acid oxidation.
    Schmidt-Sommerfeld E; Penn D; Duran M; Rinaldo P; Bennett MJ; Santer R; Stanley CA
    Prog Clin Biol Res; 1992; 375():355-62. PubMed ID: 1438381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening of A985 to G mutation of medium-chain acyl-CoA dehydrogenase (MCAD) gene in Normandy. Evaluation of the role of MCAD deficiency in sudden infant death].
    Lecoq I; Mallet E; Bonté JB; Laroche D; Travert G
    C R Seances Soc Biol Fil; 1995; 189(2):295-301. PubMed ID: 8590228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.